Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial

Agitation is a prevalent and difficult-to-treat symptom in patients with moderate-to-severe Alzheimer's disease (AD). Though there are nonpharmacological and pharmacological interventions recommended for the treatment of agitation, the efficacy of these are modest and not always consistent. Fur...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruthirakuhan, Myuri T., Herrmann, Nathan, Gallagher, Damien, Andreazza, Ana C., Kiss, Alexander, Verhoeff, Nicolaas Paul L.G., Black, Sandra E., Lanctôt, Krista L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627000/
https://www.ncbi.nlm.nih.gov/pubmed/31338476
http://dx.doi.org/10.1016/j.conctc.2019.100385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627000/
https://www.ncbi.nlm.nih.gov/pubmed/31338476
http://dx.doi.org/10.1016/j.conctc.2019.100385

Ejemplares similares